Medigen’s vaccines are intended primarily for high-impact emerging pathogens capable of causing global epidemics and pandemics. Our goal is to protect human life with life-long immunity. 

The increase in global travel, climate changes, urbanization, and other factors favor expansion of emerging diseases to new areas. We develop safe and effective vaccines that can be used by the first responders and emergency personnel, travelers, and local populations in the affected areas. In addition, our vaccines can be stockpiled for emergency use if the diseases spread to new areas. 

Medigen also develops vaccines for chronic conditions such as cancer. Our advantage is the inherent biological safety “by design” and unsurpassed efficacy of our vaccines. Each vaccine is custom-designed for a particular disease in order to ensure safety and effectiveness in all populations. 

For more information about Medigen vaccines and technologies, please contact


Chikungunya virus (CHIKV) causes chikungunya fever, a global infectious disease. The virus is found worldwide including Europe and the U.S.  CHIKV is transmitted to [...]


There are 18 different hemagglutinin (H) subtypes and 11 different neuraminidase (N) subtypes of influenza A virus, as well as two lineages of influenza [...]

Lassa fever

Lassa fever is a hemorrhagic fever caused by the Lassa virus that commonly spreads to humans in Africa from the rodent Mastomys natalensis. Symptoms [...]

Yellow Fever

Yellow fever (YF) causes an acute hemorrhagic fever disease in tropical Africa and Latin America. The YF vaccine YF17D is available and is prepared [...]

Dengue and Zika

Dengue and Zika viruses are mosquito-borne flaviviruses related to Japanese encephalitis and yellow fever viruses. Estimates indicate ~400 million of dengue infections per year, [...]


Prostate cancer is the most common cancer in men. In 2014 (the most recent year for which numbers are available) 172,258 men in the [...]